Home | Business News | CBJ Newsmakers | ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation RecommendedValour Inc. Announces Change of AuditorReal Estate Split Corp. Establishes At-The-Market Equity ProgramLeonovus Announces Bridge Loan
